XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue $ 1,390 $ 1,279 $ 2,449 $ 2,956
Revenue, Product and Service [Extensible Enumeration] Grant [Member] Grant [Member] Grant [Member] Grant [Member]
Operating expenses:        
Research and development $ 1,246 $ 2,773 $ 3,002 $ 5,536
General and administrative 1,682 2,203 4,521 4,416
Total operating expenses 2,928 4,976 7,523 9,952
Operating loss (1,538) (3,697) (5,074) (6,996)
Other income (expense):        
Interest income 27 67 28 139
Interest expense   (27) (548) (61)
Financing expenses 150 (3,545) (3,061) (3,545)
Warrant issuance costs   (432) (964) (432)
Change in fair value of derivative instruments 6,512 4,694 (2,631) 4,694
Total other income (expense) 6,689 757 (7,176) 795
Net income (loss) $ 5,151 $ (2,940) $ (12,250) $ (6,201)
Net income (loss) per share of common stock - basic $ 0.02 $ (0.45) $ (0.5) $ (1.15)
Weighted average number of shares of common stock outstanding - basic 48,388,862 6,500,831 24,422,125 5,411,382
Net loss per share of common stock - diluted $ (0.01) $ (0.71) $ (0.5) $ (1.45)
Weighted average number of shares of common stock outstanding - diluted 209,154,994 10,742,924 24,422,125 7,532,428